5.42

1.99% -0.11

Shattuck Labs Inc (STTK)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Shattuck Labs Inc stock is traded at $5.42, with a volume of 647.87K. It is down -1.99% in the last 24 hours and down -7.82% over the past month. Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Previous Close:

$5.53

Open:

$5.53

24h Volume:

647.87K

Relative Volume:

0.51

Market Cap:

$543.97M

Revenue:

$1,000.00K

Net Income/Loss:

$-48.81M

P/E Ratio:

-7.0053

EPS:

-0.7737

Net Cash Flow:

$-39.95M

1W Performance:

-9.21%

1M Performance:

-7.82%

6M Performance:

-26.26%

1Y Performance:

+201.11%

1-Day Range:

$5.27

$5.55

1-Week Range:

$5.1925

$6.21

52-Week Range:

$1.72

$8.33

Shattuck Labs Inc Stock (STTK) Company Profile

Name

Shattuck Labs Inc

Sector

Healthcare (1052)

Industry

Biotechnology (594)

Phone

512-900-4690

Address

500 W. 5TH STREET, AUSTIN

Employee

Twitter

Next Earnings Date

2026-11-05

Latest SEC Filings

STTK's Discussions on Twitter

Compare STTK vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STTK Shattuck Labs Inc	5.42	543.97M	1,000.00K	-48.81M	-39.95M	-0.7737
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-12-26	Initiated	UBS	Buy
Aug-24-26	Initiated	Raymond James	Strong Buy
Jul-20-26	Initiated	Leerink Partners	Outperform
Apr-27-26	Initiated	Cantor Fitzgerald	Overweight
Mar-06-26	Resumed	Needham	Buy
Jan-28-26	Initiated	Piper Sandler	Overweight
Dec-01-25	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-08-25	Initiated	Wedbush	Outperform
Mar-17-25	Initiated	Leerink Partners	Outperform
Oct-02-24	Downgrade	Citigroup	Buy → Neutral
Oct-02-24	Downgrade	Needham	Buy → Hold
Oct-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Aug-31-22	Initiated	BTIG Research	Buy
Jun-01-22	Initiated	Citigroup	Buy
May-02-22	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Berenberg	Buy
Jan-11-21	Initiated	Evercore ISI	Outperform
Nov-03-20	Initiated	Citigroup	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Needham	Buy

View All

Shattuck Labs Inc Stock (STTK) Latest News

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage - Investing.com Canada

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage - Investing.com Nigeria

Sep 08, 2026

Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage By Investing.com - Investing.com South Africa

Sep 08, 2026

Sep 04, 2026

SHATTUCK LABS STOCK : BIG PRICE RECOVERY | STTK STOCK Darpa Autonomous Drone Swarms (RwCs7APen5) - Mshale

Sep 04, 2026

Sep 02, 2026

Shattuck Labs Announces Participation in Upcoming September Investor Conferences - Investing News Network

Sep 02, 2026

Shattuck Labs (STTK) Gains 2.81% to $7.06 as Momentum Builds Above Key SupportDealer Positioning - dars.gov.et

Sep 02, 2026

Sep 01, 2026

Shattuck Labs: A Receptor-Side Bet On The TL1A Boom - Seeking Alpha

Sep 01, 2026

Aug 28, 2026

STTK Q2 2026 Earnings: Fractional EPS Miss Triggers 6.67% Selloff in Clinical-Stage BiotechUpward Estimate Revision - vinanet.vn

Aug 28, 2026

Aug 25, 2026

SHATTUCK LABS STOCK : BIG PRICE RECOVERY | STTK STOCK Darpa Autonomous Drone Swarms (RwCs7APen5) - Mshale

Aug 25, 2026

Aug 24, 2026

Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target - marketscreener.com

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating By Investing.com - Investing.com India

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating - Investing.com

Aug 24, 2026

Raymond James initiates Shattuck Labs stock with strong buy rating By Investing.com - Investing.com UK

Aug 24, 2026

What Shattuck Labs Stock Topped the Market on Monday - Yahoo Finance

Aug 24, 2026

Aug 23, 2026

Shattuck (STTK) EPS and Revenue: The EPS Result Is Above Expectation at the Close; Share Response: Shares Move 3.86% Up for the Current SessionEarnings Expansion Phase - vinanet.vn

Aug 23, 2026

Aug 22, 2026

Shattuck (STTK) Momentum: Records a 3.86% Increase to $7.53 in the Latest Reading; Level Watch: the $7.15 to $7.91 Range Remains in Focus in the Latest SessionSweep Order Flow - vinanet.vn

Aug 22, 2026

Aug 20, 2026